Department of Orthopaedic Surgery, Rothman Institute, Philadelphia, PA.
Department of Orthopaedic Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH.
J Arthroplasty. 2019 Sep;34(9):1963-1968. doi: 10.1016/j.arth.2019.04.040. Epub 2019 Apr 26.
Currently, the decision to resurface the patella is often made irrespective of the presence of patellar arthritis. The purpose of this study is to utilize the existing literature to assess cost-utility of routinely vs selectively resurfacing the patella.
Prospective randomized studies of patella resurfacing vs non-resurfacing in total knee arthroplasty (TKA) were identified through literature review. Data from these studies represented probabilities of varied outcomes following TKA dependent upon patella resurfacing. Using previously validated utility scores from the McKnee modified Health Utilities Index, endpoint utility values were provided for each potential outcome.
Literature review yielded a total of 14 studies with 3,562 patients receiving 3,823 TKAs, of which 1,873 (49.0%) patellae were resurfaced. Persistent postoperative anterior knee pain occurred in 20.9% vs 13.2% (P < .001) and patella reoperation was performed in 3.7% vs 1.6% (P < .001) of unresurfaced and resurfaced patella, respectively. In studies excluding those with arthritic patellae, the incidence of anterior knee pain was equivalent between groups and reoperation decreased to 1.2% vs 0% (P = .06). Patella resurfacing provided marginally improved quality-adjusted life-years (QALY) for both selective and indiscriminate patella resurfacing. When including all studies, the incremental cost per QALY was $3,032. However, when analyzing only those studies with nonarthritic patellae, the incremental cost per QALY to resurface the patella increased to $183,584.
Patellar resurfacing remains a controversial issue in TKA. Utilizing data from new prospective randomized studies, this analysis finds that routinely resurfacing arthritis-free patellae in TKA are not cost-effective.
目前,髌骨再成形术的决策通常是在不论是否存在髌骨关节炎的情况下做出的。本研究的目的是利用现有文献评估常规与选择性髌骨再成形术的成本-效用。
通过文献回顾,确定了全膝关节置换术(TKA)中髌骨再成形术与非再成形术的前瞻性随机研究。这些研究的数据代表了 TKA 后各种结果的概率,取决于髌骨再成形术。使用 McKnee 改良健康效用指数的先前验证效用评分,为每种潜在结果提供了终点效用值。
文献综述共获得 14 项研究,涉及 3562 名接受 3823 例 TKA 的患者,其中 1873 例(49.0%)髌骨进行了再成形术。未再成形组术后持续性前膝痛发生率为 20.9%,而再成形组为 13.2%(P<.001),未再成形组和再成形组髌骨再手术发生率分别为 3.7%和 1.6%(P<.001)。在排除关节炎性髌骨的研究中,两组间的前膝痛发生率相当,再手术率降至 1.2%对 0%(P=0.06)。选择性和非选择性髌骨再成形术均为髌骨再成形术提供了略有改善的质量调整生命年(QALY)。当包括所有研究时,每 QALY 的增量成本为 3032 美元。然而,当仅分析无关节炎性髌骨的研究时,再成形髌骨的每 QALY 的增量成本增加至 183584 美元。
髌骨再成形术在 TKA 中仍是一个有争议的问题。利用来自新的前瞻性随机研究的数据,本分析发现,在 TKA 中常规再成形无关节炎性髌骨并不可行。